Nacuity Pharmaceuticals, Inc.

Nacuity Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for oxidative stress, a key driver of many blinding eye diseases and serious chronic conditions. Their powerful, targeted therapies aim to stop oxidative tissue damage by boosting glutathione levels, the body's most effective endogenous antioxidant. Nacuity has a robust pipeline of highly differentiated clinical programs including retinitis pigmentosa, cataracts, and cystinosis, with a mission to bring first-of-a-kind therapies to underserved patient communities.

Nacuity is backed by Foundation Fighting Blindness and the RD Fund, and is based in Fort Worth, Texas. The company is led by veterans of Alcon Laboratories with experience in research, development, and commercialization of products to address ophthalmic diseases. Nacuity's core science is based on the extensive research of Dr. Peter Campochiaro of the Wilmer Eye Institute involving oxidative stress in the retina.

Nacuity Pharmaceuticals is a clinical-stage company developing treatments for blinding eye diseases and serious chronic conditions caused by oxidative stress. They are committed to creating powerful, targeted therapies that aim to stop oxidative tissue damage, a key factor in these diseases. Nacuity is dedicated to bringing relief to underserved patient communities and improving their quality of life.

Nacuity Pharmaceuticals promotes a culture driven by innovation, collaboration, and a strong commitment to patient well-being. The company is founded by veterans of Alcon Laboratories with extensive experience in research, development, and commercialization of ophthalmic products. This background is reflected in their focus on scientific excellence and pursuit of first-in-class therapies for blinding eye diseases and serious chronic conditions. Their leadership team consists of experts from various fields, creating a dynamic and diverse environment. They are also actively involved with organizations like Foundation Fighting Blindness, demonstrating their dedication to improving the lives of patients.